Silence Starts Phase Ia/IIb Trial of Cancer Drug as It Looks to Balance Pipeline

Share:

Silence Starts Phase Ia/IIb Trial of Cancer Drug as It Looks to Balance Pipeline

Silence Starts Phase Ia/IIb Trial of Cancer Drug as It Looks to Balance Pipeline GenomeWeb If no toxicity is observed, the phase IIa arm of the trial will begin with pancreatic cancer patients receiving the two drugs once a week for three consecutive weeks, with no treatment on the fourth week. This dosing schedule will continue in … http://www.genomeweb.com/rnai/silence-starts-phase-iaiib-trial-cancer-drug-it-looks-balance-pipeline

Tweet